US Patent 11945834 Cyclic dinucleotides as anticancer agents
Patent 11945834 was granted and assigned to Bristol-Myers Squibb Company on April, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11945834 Cyclic dinucleotides as anticancer agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
